212
A. Cimmino et al. / Phytochemistry 96 (2013) 208–213
Food Production, Bari, Italy (ITEM 12534). The isolate was routinely
grown and maintained in plates and slants containing potato-
dextrose agar (PDA, Sigma–Aldrich, Chemie Gmbh, Buchs,
Switzerland).
(loge
): 328 (3.8), 227 (4.3); 1H NMR spectrum, d 6.51 (s, H-5),
6.21 (s, H-7a), 5.00 (q, J = 6.4 Hz, H-11), 3.91 (s, OMe), 2.20 (s,
Me-13), 2.08 (s, MeCO), 1.94 (s, Me-8), 1.39 (s, Me-9), 1.26 (d,
J = 6.4 Hz, Me-12); ESIMS (+) m/z: 643 [2M+Na]+, 349 [M+K]+,
333 [M+Na]+, 315 [M+NaÀH2O]+; APCIMS (+) m/z: 311 [M+H]+,
293 [M+HÀH2O]+, 233 [M+HÀAcOH]+.
3.3. Production, extraction, and purification of chenopodolans A–C
(1–3)
3.8. 11-O-(S)-
a
-methoxy-
a
-trifluoromethyl-
a
-phenylacetate (MTPA)
The fungus was grown in 1 L Erlenmeyer flasks containing
300 mL of a defined mineral (Pinkerton and Strobel, 1976) as re-
cently described (Cimmino et al., 2013). The material obtained by
lyophilising the culture filtrates (4.6 L) of the fungus was extracted
by EtOAc (4 Â 1 L); the organic extract (1.04 g), having high phyto-
toxic activity, was fractionated by CC eluted with the solvent
system A, as already described (Cimmino et al., 2013). Ten homo-
geneous fraction groups were collected and groups from 1 to 6
proved to be phytotoxic. The purification of the residue of fraction
6 (62 mg) led to obtain chenopodolin. The residue (39 mg) of frac-
tion 5 of the original column was further purified by preparative
TLC, eluted with solvent system A, yielding two homogenous solid
compounds that, being two new furopyrans, were named chenop-
odolan A and B (1, Rf 0.39, 5.6 mg, 1.2 mg/L, 2, Rf 0.53, 3.1 mg,
0.7 mg/L, respectively). The purification by TLC of the residue
(13.7 mg) of fraction 4 (eluent system A) yielded a white amor-
phous solid (7, Rf 0.67, 8.7 mg, 1.9 mg/L) which was identified as
(À)-(R)-6-hydroxymellein, as reported below. The purification of
the residue of fraction 1 (30 mg) by preparative TLC, eluted with
the solvent system B, yielded a yellow homogeneous solid; being
a new furopyran it was named chenopodolan C (3, Rf 0.45,
10.4 mg, 2.3 mg/L).
ester of 1 (5)
(R)-(À)-MPTA-Cl (20
dry pyridine (20
l
L) was added to 1 (1.0 mg) dissolved in
l
L). The mixture was kept at room temperature
for 1 h and then the reaction stopped by adding MeOH. Pyridine
was removed by an N2 stream. The residue (2.5 mg) was purified
by preparative TLC, eluted with solvent system D, yielding 5 as a
homogeneous oil (Rf 0.31, 1.1 mg). It had: IR mmax 3456, 1725,
1679, 1657, 1550, 1275 cmÀ1; UV kmax nm (log
e) 271 (3.34) 224
(sh); 1H NMR spectrum see Table 4; ESIMS (+) m/z 507 [M+Na]+.
3.9. 11-O-(R)-a-methoxy-a-trifluoromethyl-a-phenylacetate (MTPA)
ester of 1 (6)
(S)-(+)-MPTA-Cl (20
dry pyridine (20 L). The reaction was carried out under the same
lL) was added to 1 (1.0 mg) dissolved in
l
conditions used for preparing 5 from 1. The purification of the
crude residue (2.2 mg) by preparative TLC eluted with solvent sys-
tem D, allowed to obtain 6 as a homogeneous oil (Rf 0.31, 1.2 mg).
It had: IR mmax 3472, 1728, 1676, 1657, 1597, 1273 cmÀ1; UV kmax
nm (loge
) 270 (3.31), 225 (sh); 1H NMR spectrum see Table 4;
ESIMS (+) m/z 507 [M+Na]+.
3.4. Chenopodolan A (1)
3.10. (À)-(R)-6-hydroxymellein (7)
25
25
Compound 1: [
a
]
D: +8.5 (c = 0.24); IRmmax 3407, 1679, 1618,
) 307 (3.7), 214 (4.2); 1H and
Compound 7, had: [
a]
D: À40.0 (c = 0.4, MeOH); IRmmax 3544,
18
1555, 1456 cmÀ1; UV kmax nm (log
e
1664, 1625, 1585, 1540, 1251 cmÀ1 [lit, Islam et al., 2007: [
À51 (c = 0.10, MeOH); IR (KBr) = 3600–2800, 1651, 1632, 1587,
a
]
:
D
13C NMR spectra: see Table 1; HRESI MS (+) m/z: 559 [2M+Na]+,
307 [M+K]+, 291.1217 [M+Na]+ (calcd for C14H20NaO5 291.1208),
273 [M+NaÀH2O]+; APCIMS (+) m/z: 269 [M+H]+, 251
[M+HÀH2O]+.
m
1503, 1477, 1386, 1290, 1257, 1221, 1195, 1170, 1120, 1067,
854, 796, 737 cmÀ1]; 1H NMR spectrum is very similar to that pre-
viously reported and recorded (Islam et al., 2007) in the same con-
ditions, except for the following signals, d: 2.88 (1H, dd, J = 16.0
and 10.0 Hz, H-4A), 2.84 (1H, dd, J = 16.0 and 6.0 Hz, H-4B); ESIMS
(+) m/z 217 [M+Na]+; ESIMS (À) m/z 193 [MÀH]À; APCIMS (+) m/z
195 [M+H]+.
3.5. Chenopodolan B (2)
25
Compound 2: [a] D: +8.6 (c = 0.20); IR mmax 3417, 1673, 1610,
1547, 1454 cmÀ1; UV kmax nm (log ) 303 (3.8), 214 (4.3); 1H and
e
13C NMR spectra: see Table 1; HRESI MS (+) m/z: 471 [2M+Na]+,
263 [M+K]+, 247.0934 [M+Na]+ (calcd for C12H16NaO4 247.0946),
229 [M+NaÀH2O]+; APCI m/z: 225 [M+H]+, 207 [M+HÀH2O]+.
3.11. Biological activities
Each metabolite was first dissolved in a minimum amount of
MeOH (10À1 M or not higher than 2% in the final solutions) and
then diluted with distilled water to the desired concentrations.
The following bioassays were performed:
3.6. Chenopodolan C (3)
25
Compound 3: [
a
]
D: +4.6 (c = 0.20); IR mmax 1673, 1626, 1607,
Leaf puncture assay: The compounds were tested by using a leaf
puncture assay on 3 plant species (C. album L., M. annua L., and
S. oleraceus L.) (Evidente et al., 2005). Pure compounds were tested
1547 cmÀ1; UV kmax nm (log ) 336 (3.6), 253 (3.7); 1H and 13C
e
NMR spectra: see Table 1; HRESI MS (+) m/z: 725 [3M+Na]+, 491
[2M+Na]+, 273 [M+K]+, 257.1164 [M+Na]+ (calcd for C14H18NaO3
257.1154), 235.1343 [M+H]+ (calcd for C14H19O3 235.1334).
at 6.85 Â 10À3 M by applying a droplet (20
ll, 2% MeOH) of solu-
tion to detached leaves previously punctured with a needle. Five
replications (droplets) on separate leaves were used for each
metabolite and for each plant species tested. Leaves were kept in
a moistened chamber under continuous fluorescent lights. Symp-
toms were estimated visually between 3 and 5 days after droplet
application, by using a visual scale from 0 (no symptoms) to 4
(necrosis wider than 1 cm). Control treatments were carried out
by applying droplets not containing the metabolites.
3.7. 11-O-Acetylchenopodolan A (4)
Chenopodolan A (1, 2.5 mg) was acetylated with pyridine
(50 lL) and Ac2O (50 lL) at room temperature for 1 h. The reaction
was stopped by addition of MeOH and the azeotrope, obtained by
the addition of benzene, was evaporated by an N2 stream. The oily
residue (5.0 mg) was purified by preparative TLC eluted with the
solvent system C, to give the 11-O-acetyl derivative 4 of chenopod-
olan A as a homogeneous compound (Rf 0.62, 2.4 mg). Derivative 4
had: IR mmax 3423, 1733, 1676, 1615, 1552, cmÀ1; UV kmax nm
Antimicrobial bioassay: The antimicrobial activity was tested
against three microorganisms by using an agar diffusion
assay according to the protocol previously described (Bottalico
et al., 1990). In particular, the antifungal activity was tested on